Eric Rhoden

460 total citations
17 papers, 327 citations indexed

About

Eric Rhoden is a scholar working on Cardiology and Cardiovascular Medicine, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Eric Rhoden has authored 17 papers receiving a total of 327 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 8 papers in Infectious Diseases and 5 papers in Molecular Biology. Recurrent topics in Eric Rhoden's work include Viral Infections and Immunology Research (11 papers), Viral gastroenteritis research and epidemiology (8 papers) and Estrogen and related hormone effects (2 papers). Eric Rhoden is often cited by papers focused on Viral Infections and Immunology Research (11 papers), Viral gastroenteritis research and epidemiology (8 papers) and Estrogen and related hormone effects (2 papers). Eric Rhoden collaborates with scholars based in United States, Austria and United Kingdom. Eric Rhoden's co-authors include M. Steven Oberste, W. Allan Nix, Mingyu Zhang, Hongmei Liu, Marc S. Collett, Jillian R. Gunther, Terry W. Moore, John A. Katzenellenbogen, Yuhong Du and Haian Fu and has published in prestigious journals such as Journal of Medicinal Chemistry, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Eric Rhoden

16 papers receiving 320 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric Rhoden United States 11 176 114 98 67 54 17 327
Sainan Wang China 13 37 0.2× 222 1.9× 143 1.5× 100 1.5× 20 0.4× 36 524
Jessica Freeling United States 11 70 0.4× 74 0.6× 193 2.0× 41 0.6× 15 0.3× 20 395
Vi T. Dang Australia 11 75 0.4× 158 1.4× 139 1.4× 90 1.3× 45 0.8× 16 368
Richard T. Wiedmann United States 13 186 1.1× 74 0.6× 161 1.6× 151 2.3× 18 0.3× 25 478
Izuru Nakamura Japan 12 71 0.4× 101 0.9× 213 2.2× 68 1.0× 23 0.4× 28 380
Miao Xu United States 11 27 0.2× 171 1.5× 158 1.6× 45 0.7× 17 0.3× 22 416
Catherine A. Doyle United States 9 63 0.4× 91 0.8× 129 1.3× 199 3.0× 17 0.3× 12 455
Binbin Zhao China 11 28 0.2× 99 0.9× 173 1.8× 82 1.2× 24 0.4× 19 374
John C.H. Steele United States 11 25 0.1× 65 0.6× 183 1.9× 98 1.5× 16 0.3× 25 493
Alessandro Cinti Canada 12 34 0.2× 75 0.7× 160 1.6× 52 0.8× 17 0.3× 15 375

Countries citing papers authored by Eric Rhoden

Since Specialization
Citations

This map shows the geographic impact of Eric Rhoden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Rhoden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Rhoden more than expected).

Fields of papers citing papers by Eric Rhoden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Rhoden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Rhoden. The network helps show where Eric Rhoden may publish in the future.

Co-authorship network of co-authors of Eric Rhoden

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Rhoden. A scholar is included among the top collaborators of Eric Rhoden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Rhoden. Eric Rhoden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Rhoden, Eric & Bernardo A. Mainou. (2024). An automated assay platform for the evaluation of antiviral compounds against polioviruses. Journal of Virological Methods. 329. 115006–115006. 1 indexed citations
2.
Xie, Hang, Eric Rhoden, Hongmei Liu, et al.. (2024). Antiviral Development for the Polio Endgame: Current Progress and Future Directions. Pathogens. 13(11). 969–969.
3.
Rhoden, Eric, Bernardo A. Mainou, Jennifer L. Konopka‐Anstadt, & M. Steven Oberste. (2022). An automated high-throughput enterovirus D68 microneutralization assay platform. Journal of Virological Methods. 308. 114590–114590. 1 indexed citations
4.
Rhoden, Eric, Terry Fei Fan Ng, Raymond P. Campagnoli, et al.. (2019). Antifungal Triazole Posaconazole Targets an Early Stage of the Parechovirus A3 Life Cycle. Antimicrobial Agents and Chemotherapy. 64(3). 9 indexed citations
5.
Madia, Valentina Noemi, Antonella Messore, Luca Pescatori, et al.. (2018). In Vitro Antiviral Activity of New Oxazoline Derivatives as Potent Poliovirus Inhibitors. Journal of Medicinal Chemistry. 62(2). 798–810. 10 indexed citations
6.
Rhoden, Eric, W. Allan Nix, William C. Weldon, & Rangaraj Selvarangan. (2017). Antifungal azoles itraconazole and posaconazole exhibit potent in vitro antiviral activity against clinical isolates of parechovirus A3 (Picornaviridae). Antiviral Research. 149. 75–77. 19 indexed citations
7.
Lu, Yao, et al.. (2017). User performance evaluation and real-time guidance in cloud-based physical therapy monitoring and guidance system. Multimedia Tools and Applications. 78(7). 9051–9081. 12 indexed citations
8.
Collett, Marc S., Kimberley Benschop, Erwin Duizer, et al.. (2016). Antiviral activity of pocapavir in a randomized, blinded, placebo-controlled human oral poliovirus vaccine challenge model. The Journal of Infectious Diseases. 215(3). jiw542–jiw542. 50 indexed citations
9.
Rhoden, Eric, Mingyu Zhang, W. Allan Nix, & M. Steven Oberste. (2015). In Vitro Efficacy of Antiviral Compounds against Enterovirus D68. Antimicrobial Agents and Chemotherapy. 59(12). 7779–7781. 51 indexed citations
10.
Cataldi, Jessica R., et al.. (2015). Use of Investigational Antiviral Drug Pocapavir to Treat Enteroviral Sepsis in Twin Neonates. Open Forum Infectious Diseases. 2(suppl_1). 4 indexed citations
11.
Tijsma, Aloys, Hendrik Jan Thibaut, Stéphane A. Spieser, et al.. (2014). H1PVAT is a novel and potent early-stage inhibitor of poliovirus replication that targets VP1. Antiviral Research. 110. 1–9. 12 indexed citations
12.
Myers, Angela, et al.. (2014). First Use of Investigational Antiviral Drug Pocapavir (V-073) for Treating Neonatal Enteroviral Sepsis. The Pediatric Infectious Disease Journal. 34(1). 52–54. 31 indexed citations
13.
14.
Nessler, Jeff A., et al.. (2011). Stride Interval Dynamics Are Altered when Two Individuals Walk Side by Side. Motor Control. 15(3). 390–404. 15 indexed citations
15.
Sun, Aiming, Terry W. Moore, Jillian R. Gunther, et al.. (2011). Discovering Small‐Molecule Estrogen Receptor α/Coactivator Binding Inhibitors: High‐Throughput Screening, Ligand Development, and Models for Enhanced Potency. ChemMedChem. 6(4). 654–666. 35 indexed citations
16.
Gunther, Jillian R., Yuhong Du, Eric Rhoden, et al.. (2009). A Set of Time-Resolved Fluorescence Resonance Energy Transfer Assays for the Discovery of Inhibitors of Estrogen Receptor-Coactivator Binding. SLAS DISCOVERY. 14(2). 181–193. 43 indexed citations
17.
Durley, Richard C., et al.. (1996). Isolation and Structure of Leukotriene-A4 Hydrolase Inhibitor:  8(S)-Amino-2(R)-methyl-7-oxononanoic Acid Produced by Streptomyces diastaticus. Journal of Natural Products. 59(10). 962–964. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sainan Wang Breakdown of academic impact, for papers by Jessica Freeling Breakdown of academic impact, for papers by Vi T. Dang Breakdown of academic impact, for papers by Richard T. Wiedmann Breakdown of academic impact, for papers by Izuru Nakamura Breakdown of academic impact, for papers by Miao Xu Breakdown of academic impact, for papers by Catherine A. Doyle Breakdown of academic impact, for papers by Binbin Zhao Breakdown of academic impact, for papers by John C.H. Steele Breakdown of academic impact, for papers by Alessandro Cinti
Rankless by CCL
2026